Our previous study has been the only one thus far to evaluate the safety and feasibility of suicide gene therapy using autologous bone marrow-derived MSCs (BMSCs) carrying the HSV-TK gene in patients with newly diagnosed GBM [17]. This evidence concerns the gene TKT and glioblastoma.